A Study for the Treatment of Painful Diabetic Neuropathy
CompletedPhase 3NCT00058968
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of the study is to determine if duloxetine can help patients with painful diabetic neuropathy.
Study details
- Official title
- Duloxetine Versus Placebo in the Treatment of Patients With Painful Diabetic Neuropathy
- Conditions
- Diabetic Neuropathy, Painful
- Interventions
- Drug: Duloxetine hydrochloride
- Drug: placebo
- Sponsor
- Eli Lilly and Company
- Start date
- 2002-10
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Male or female outpatients at least 18 years of age. * Patients with pain due to diabetic neuropathy in both legs. * Females must not be pregnant or plan to become pregnant during the study. * Stable Glycemic control. * Average mean pain severity score of at least 4.0 as assessed by completion of a daily diary. Exclusion Criteria: * You are related to or work for the physician conducting the study or are employed by Eli Lilly and Company. * You have a severe or serious medical condition that causes you to be hospitalized often; or you have had a kidney transplant or are on current dialysis. * You have participated in a study for an investigational drug within the last 30 days. * You have a history of major depressive disorder, generalized anxiety disorder, or alcohol or eating disorders. * You have a past medical history or diagnosis of mania, bipolar disorder, or psychosis.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00058968